Overview

Gastric Cancer Prevention in the Family Members by Helicobacter Pylori Eradication

Status:
Active, not recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study evaluate whether treatment of Helicobacter pylori infection reduces the incidence of gastric cancer in subjects with family history of gastric cancer.
Phase:
Phase 3
Details
Lead Sponsor:
National Cancer Center, Korea
Treatments:
Amoxicillin
Clarithromycin
Lansoprazole